How strong is the evidence that GLP-1 drugs protect the kidneys along with the heart?Studies have shown that GLP-1 drugs can slow down worsening kidney function, lower protein leakage in urine and reduce cardiovascular complications in patients with kidney disease
Finally, we found that the effect of liraglutide to increase bihormonal insulin + glucagon + cells was mediated by the cell GLP-1R in mice
The authors speculate that the expression of VE-cadherin may represent a reversion to a more primitive, embryonal phenotype
196 Depletion of the tumor suppressor BAP1 in normal human cholangiocyte organoids results in impaired chromatin accessibility, loss of multiple epithelial features, and increased motility
We believe an improved once-daily formulation of danuglipron could play an important role in our obesity treatment paradigm, and we will focus our efforts on gathering the data to understand its potential profile, said Mikael Dolsen, chief scientific officer and president at Pfizer Research and Development, in a statement